Transamerica Financial Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-158
Closed -$12K 2233
2026
Q1
$12K Buy
158
+119
+305% +$8.95K ﹤0.01% 881
2025
Q4
$2.89K Buy
39
+2
+5% +$146 ﹤0.01% 1061
2025
Q3
$2.43K Buy
37
+33
+825% +$2.19K ﹤0.01% 1009
2025
Q2
$197 Hold
4
﹤0.01% 495
2025
Q1
$1K Hold
4
﹤0.01% 484
2024
Q4
$1K Hold
4
﹤0.01% 479
2024
Q3
$1K Sell
4
-945
-100% -$75.6K ﹤0.01% 486
2024
Q2
$71K Hold
949
0.01% 257
2024
Q1
$74K Sell
949
-3,665
-79% -$273K 0.01% 281
2023
Q4
$330K Sell
4,614
-825
-15% -$57.4K 0.05% 205
2023
Q3
$378K Sell
5,439
-734
-12% -$55.5K 0.05% 178
2023
Q2
$500K Sell
6,173
-84
-1% -$6.86K 0.06% 176
2023
Q1
$505K Buy
6,257
+610
+11% +$49.1K 0.07% 177
2022
Q4
$423K Buy
5,647
+1,707
+43% +$122K 0.06% 176
2022
Q3
$255K Sell
3,940
-81
-2% -$5.61K 0.04% 202
2022
Q2
$279K Buy
+4,021
New +$299K 0.04% 202

Other funds holding HOLX

Transamerica Financial Advisors's HOLX Position: Q2 2026 in Review

Transamerica Financial Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 158 shares — an estimated $12K sold.

Transamerica Financial Advisors first reported a position in HOLX in Q2 2022 and held it in 16 quarters. The position peaked at $505K in Q1 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Transamerica Financial Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Transamerica Financial Advisors sold 158 Hologic shares in Q2 2026, an estimated $12K.
  • Transamerica Financial Advisors first reported a position in Hologic in Q2 2022 and held it in 16 quarters.
  • Transamerica Financial Advisors's Hologic position peaked at $505K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.